Overview of defibrillators and their role in cardiac care
Allied Market Research released a report on the defibrillators market. The industry was valued at $13,168 million in 2020 and is anticipated to attain $24,608.3 million by 2030.
Overview of defibrillators and their role in cardiac care
A defibrillator is a medical device used to restore a normal heart rhythm and thus save the life of the individual. It is used for treating patients experiencing life-threatening cardiac arrhythmias, or sudden cardiac arrest, or a medical emergency that requires immediate intervention. It helps deliver a controlled electrical shock to the heart. This helps reset the activity of the health and allows normal rhythm to resume.
Manual external defibrillators, automated external defibrillators, wearable cardioverter defibrillators, and implantable cardioverter defibrillators are the different types of defibrillators. Manual external defibrillators are used by trained healthcare professionals in hospitals and emergency medical services. Automated external defibrillators provide voice and visual prompts to guide users through the defibrillation process. Implantable cardioverter defibrillators are surgically placed inside patients at high risk of sudden cardiac arrest. Wearable cardioverter defibrillators are used by patients who require temporary protection.
Allied Market Research released a report on the defibrillators market. The industry was valued at $13,168 million in 2020 and is anticipated to attain $24,608.3 million by 2030. The AMR report offers industry insights and trends along with market dynamics. This helps the stakeholders make strategic decisions. The industry is segmented into product, end user, and region. By product, the implantable defibrillators segment is anticipated to experience growth during the study period; by end user, the hospitals segment held the highest share in 2020.
Region-wise, North America held the highest share in 2020. This was attributed to advancements in healthcare infrastructure and increase in awareness of cardiac emergencies. Europe witnesses growth owing to increase in focus on favorable healthcare policies and rise in adoption of implantable and wearable defibrillators. The Asia-Pacific region is expected to experience rapid growth due to rise in prevalence of cardiovascular disease and increase in government initiatives that help improve emergency response systems. LAMEA exhibits steady growth potential, driven by improvements in healthcare access and surge in awareness of sudden cardiac arrest management.
Factors influencing growth of the defibrillator sector
Rise in prevalence of cardiovascular diseases and surge in number of sudden cardiac arrest cases drive the growth of the defibrillator sector. In addition, sedentary lifestyles, aging populations, and obesity also contribute to the growth of the sector. Increase in emphasis on public access defibrillation programs also foster the defibrillator sector growth. However, high costs associated with advanced defibrillators limit the growth of the defibrillator sector. In addition, the need for regular maintenance and battery replacement increases the total cost of ownership, which further deters the growth of the sector. Despite the challenges, innovation in technology and integration of artificial intelligence and remote monitoring are opportunistic for the growth of the sector.
Innovations driving defibrillator evolution
Incorporation of artificial intelligence and usage of advanced algorithms help enhance rhythm analysis and reduce inappropriate shocks. These systems help improve clinical outcomes while increasing patient safety. Further, the development of smaller, lighter, and portable defibrillator help improve accessibility and ease of deployment. Modern defibrillators are being designed with real-time voice guidance and visual prompts that help adapt to user actions and make them suitable for untrained individuals. Implantable cardioverter defibrillators also help reduce surgical complications and increase patient comfort. Remote monitoring capabilities allow physicians to track device performance and patient condition in real time.
List of key players
- Asahi Kasei Corporation
- Nihon Kohden Corporation
- Stryker Corporation
- Cardiac Science Corporation
- Biotronik SE & Co. KG
- Medtronic plc
- Boston Scientific Corporation
- LivaNova PLC
- Philips Healthcare
- St. Jude Medical, Inc.
Concluding notes
Defibrillators play an important role in emergency response systems. Advancements in technology enhance the effectiveness and usability of defibrillators. Modern devices feature biphasic waveform technology which delivers shocks efficiently and minimizes myocardial damage. They are integrated with monitoring functions such as electrocardiogram display, data recording, and heart rate analysis. They help healthcare providers assess patient conditions accurately. Defibrillators play an important role between emergency response and long-term management of heart rhythm disorders. Thus, the defibrillators sector is poised to experience growth in the upcoming years.
The report, published by Allied Market Research, focuses on market dynamics and key trends of the defibrillators market analysis. The study provides competitive landscape analysis of the key players to understand the adopted strategies and competitive intensity of competitors. It also offers a study of threat of new entrants, and bargaining power of buyers, on the defibrillators market outlook.